Global pain management devices market research report, type (stimulators, transcutaneous electrical nerve stimulation devices, pumps, ablation devices), application (cancer pain, musculoskeletal pain, migraine and other) – Forecast Till 2023Pain management is defined as a branch of medical science, dealing with minimizing of pain of the patients. A new report on the global pain management devices market, published by Market Research Future (MRFR), notes that this market could explore expansion at 7.2% CAGR between 2016 and 2023. In terms of money value, the market can be worth USD 5.81 Bn by the end of the forecast period.The tallest market driver for the global pain management devices market growth is the increasing number of patient suffering from different diseases. Such diseases can be due to aging, unhealthy lifestyle, lack of sleep, muscle stress, nerve-related problems, and genetic disorders. Increasing geriatric population and surging government efforts to provide more pain rehabilitation centers can boost the market. The increasing prevalence of many acute and chronic ailments has also led to market growth. In developed countries, research & development (R&D) on devices and technological advancement are opening new avenues of market growth. However, the effects of pain management devices and high cost can hinder the global pain management devices market growth.Free Report Sample At:https://www.marketresearchfuture.com/sample_request/1504Market SegmentationThe global pain management devices market segmentation encompasses application and device type. MRFR’s take on the market explores various facets of the market in-depth.The application-based segmentation of this market covers cancer pain, migraine, musculoskeletal pain, and others. During the forecast period, the cancer pain management segment can witness the highest market growth due to increased healthcare spending and the availability of reimbursement aides. These factors are leading to pain management devices market growth.By device type, the market has been segmented into ablation devices, pumps, and stimulators. Ablation devices segment has been sub-segmented into cryoablation devices, microwave devices, and others. The pumps segment has been sub-segmented into analgesic infusion pumps and other. The analgesic infusion pumps sub-segment has been further segmented into external infusion pumps, intrathecal infusion pumps, patient control infusion pumps, and other. The stimulators segment has been sub-segmented into neuromodulator devices and transcutaneous electrical nerve stimulation (TENS) devices. The neuromodulator devices sub-segment has been further segmented into dorsal root ganglion stimulation, intrathecal pain pump, a peripheral nerve stimulator, spinal cord stimulator, and other.Regional SegmentationA geographical outlining of the global pain management devices market covers North America, Asia Pacific, Europe, and the Middle East & Africa (MEA).North America holds the largest global market share, followed by Europe. In this region, the market is growing due to huge investment healthcare, availability of advanced medical facilities, presence of key market players, and development in R&D. The R&D in neurostimulation based pain management devices is supporting market growth. Maximum revenue in this region comes from the USA and Canada.The European market is mature in terms of revenue, size (due to the high density of population), and favorable reimbursement. Other factors contributing to the market include continuous technological advancements, development of novel neuropathic pain management device, a large patient population base, increasing cases of cancer patients, and increasing healthcare awareness, and surging healthcare expenditure. Due to technological advancement, the presence of some key market players, and the availability of advanced medical facilities, Western Europe is a bigger regional market segment compared to Eastern Europe. The most powerful country-specific markets in Western Europe are France, Germany, Italy, Spain, and the UK.In the Asia Pacific region, the market is witnessing the fastest growth due to development in infrastructure, a huge population base, and increasing prevalence of many diseases, and continuous efforts of the governments in the region to upgrade the healthcare standards. Vital country-specific markets in this region are Australia, China, India, Japan, and South Korea.The markets in the MEA region can witness various highs and lows during the forecast period due to the lack of sophisticated healthcare infrastructure and weak economic growth. However, the market growth in this region is steady due to the constant efforts by the governments along with massive investments by private as well as public firms that are striving to take advantage of the untapped potential of the budding market in this region.Key PlayersBig players in the global pain management devices market include Baxter International Inc. (USA), B. Braun Melsungen AG. (Germany), Bio-Medical Research (BMR) Ltd. (UK), Boston Scientific Corporation (USA), Codman and Shurtleff Inc. (USA), DJO Global LLC (USA), Hospira Inc. (USA), Kimberly-Clark Corporation (USA), Medtronic PLC (USA), Pain Management Inc. (USA), Smiths Medical (UK), St. Jude Medical (USA), and Stryker Corporation (USA).Latest Industry News
Browser Complete Report At:https://www.marketresearchfuture.com/reports/pain-management-devices-market-1504NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.About Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.